SEC Info - Burzynski Research Institute Inc - ‘10-Q’ for 5/31/12

SEC Info℠

Home

Help

Please Sign In

Burzynski Research Institute Inc – ‘10-Q’ for 5/31/12 – ‘R11’

On: Monday, 7/16/12, at 4:06pm ET · For: 5/31/12 · Accession #: 1104659-12-49123 · File #: 0-23425

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/16/12  Burzynski Research Institute Inc  10-Q        5/31/12   25:1M                                     Toppan Merrill/FA

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    203K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     16K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     13K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     13K 
19: R1          Document and Entity Information                     HTML     32K 
15: R2          Balance Sheets                                      HTML     64K 
18: R3          Balance Sheets (Parenthetical)                      HTML     27K 
20: R4          Statements of Operations                            HTML     49K 
22: R5          Statement of Stockholders' Deficit                  HTML     24K 
16: R6          Statements of Cash Flows                            HTML     50K 
17: R7          Basis of Presentation                               HTML     24K 
14: R8          Economic Dependency                                 HTML     26K 
12: R9          Stock Options                                       HTML     24K 
24: R10         Income Taxes                                        HTML     38K 
21: R11         Subsequent Events                                   HTML     14K 
25: XML         IDEA XML File -- Filing Summary                      XML     29K 
13: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS     72K 
 6: EX-101.INS  XBRL Instance -- bzyr-20120531                       XML    115K 
 8: EX-101.CAL  XBRL Calculations -- bzyr-20120531_cal               XML     53K 
 9: EX-101.DEF  XBRL Definitions -- bzyr-20120531_def                XML    118K 
10: EX-101.LAB  XBRL Labels -- bzyr-20120531_lab                     XML    361K 
11: EX-101.PRE  XBRL Presentations -- bzyr-20120531_pre              XML    191K 
 7: EX-101.SCH  XBRL Schema -- bzyr-20120531                         XSD     37K 
23: ZIP         XBRL Zipped Folder -- 0001104659-12-049123-xbrl      Zip     31K

‘R11’ — Subsequent Events

This is an IDEA Financial Report. [ Alternative Formats ]

SUBSEQUENT EVENTS

3 Months Ended

May 31, 2012

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE E. SUBSEQUENT EVENTS

Effective July 5, 2012, the Company entered into a Marketing and Consulting Agreement (the “Marketing Agreement”) with Worldwide Medical Consultants, Inc. (“WMC”) and CARIGEN, LTD (“SRB”), an entity wholly-owned and controlled by Dr. Burzynski, pursuant to which WMC will (i) provide SRB with various marketing and consulting services to assist SRB in locating and developing cancer or health related centers in certain foreign markets and (ii) make payments to the Company equal to 10% of each consulting fee received by WMC for the aforementioned services provided to SRB, net of certain expenses incurred by WMC (“WMC Payment”). In consideration of the WMC Payment, the Company agreed to grant to WMC warrants to acquire an aggregate of 2,000,000 shares of the Company’s Common Stock, exercisable at $0.10 per share with a ten year exercise period, with 1,000,000 shares vesting upon execution of the agreement and the remaining 1,000,000 shares to vest upon the first closing of a transaction by SRB as a result of the services provided by WMC under the Marketing Agreement. Through the date of this report, none of the aforementioned warrants have been exercised.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	7/16/12
	7/5/12	8-K
For Period end:	5/31/12
		List all Filings

↑Top

Filing Submission 0001104659-12-049123 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)